Browse the corpus

REFERENCES American Diabetes Association, “Standards of Medical Care in Diabetes Mellitus -- 2012,” Diabetes Care , 2012, 35(Suppl 1):11-63. [PubMed 22187469 ] Balfour JA and McTavish D, “Acarbose: A Reappraisal,” Drugs , 1993, 46(6):1025-54. [PubMed 7510610 ] Bischoff H, “Pharmacology of α-Glucosidase Inhibition,” Eur J Clin Invest , 1994, 24(Suppl 3):3-10. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, "Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada," Can J Diabetes , 20078, 32(suppl 1):1-201. Handelsman Y, Mechanick JI, Blonde L, et al, “American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan,” Endocr Pract , 2011, 17(Suppl 2):1-53. [PubMed 21474420 ] Kirkman M, Briscoe VJ, Clark N, et al, "Diabetes in Older Adults: A Consensus Report," J Am Geriatr Soc , 2012; doi: 10.1111/jgs.12035. [PubMed 23106132 ] Qaseem A, Humphrey LL, Sweet DE, et al,“Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline from the American College of Physicians,” Ann Intern Med , 2012, 156(3):218-31. [PubMed 22312141 ] Rodbard HW, Jellinger PS, Davidson JA, et al, “Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An Algorithm for Glycemic Control,” Endocr Pract , 2009, 15(6):540-59. [PubMed 19858063 ] Scheen AJ, de Magalhaes AC, Salvatore T, et al, “Reduction of the Acute Bioavailability of Metformin by the α-Glucosidase Inhibitor Acarbose in Normal Man,” Eur J Clin Invest , 1994, 24(Suppl 3):50-4. Topic 9219 Version 44.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.3 - C21.34 Licensed to: Morehouse School of Medicine | Support Tag: [0504-200.215.4.194-8300F9CC1D-S473950.14]